Edgewood Management LLC bought a new position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 226,210 shares of the medical research company's stock, valued at approximately $152,703,000. Thermo Fisher Scientific accounts for approximately 2.4% of Edgewood Management LLC's investment portfolio, making the stock its 16th biggest holding. Edgewood Management LLC owned 0.06% of Thermo Fisher Scientific as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in the business. Keeler Thomas Management LLC grew its position in Thermo Fisher Scientific by 0.9% during the 3rd quarter. Keeler Thomas Management LLC now owns 1,928 shares of the medical research company's stock worth $1,301,000 after purchasing an additional 17 shares during the period. Tsfg LLC lifted its holdings in shares of Thermo Fisher Scientific by 20.4% in the 2nd quarter. Tsfg LLC now owns 112 shares of the medical research company's stock valued at $56,000 after buying an additional 19 shares during the period. Welch Group LLC boosted its stake in shares of Thermo Fisher Scientific by 1.8% in the third quarter. Welch Group LLC now owns 1,089 shares of the medical research company's stock worth $735,000 after buying an additional 19 shares during the last quarter. Renasant Bank boosted its stake in shares of Thermo Fisher Scientific by 1.0% in the second quarter. Renasant Bank now owns 1,934 shares of the medical research company's stock worth $970,000 after buying an additional 20 shares during the last quarter. Finally, Strengthening Families & Communities LLC grew its holdings in Thermo Fisher Scientific by 0.4% during the third quarter. Strengthening Families & Communities LLC now owns 4,721 shares of the medical research company's stock worth $3,187,000 after acquiring an additional 21 shares during the period. 89.23% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on TMO shares. Morgan Stanley boosted their price target on Thermo Fisher Scientific from $650.00 to $730.00 and gave the company an "overweight" rating in a report on Monday, October 12th. Robert W. Baird lifted their target price on shares of Thermo Fisher Scientific from $723.00 to $756.00 and gave the company an "outperform" rating in a report on Thursday, October 22nd. BMO Capital Markets cut shares of Thermo Fisher Scientific to a "market perform" rating in a research note on Wednesday, September 9th. Barclays increased their price target on shares of Thermo Fisher Scientific from $750.00 to $775.00 and gave the stock an "overweight" rating in a report on Thursday, October 22nd. Finally, Scotiabank initiated coverage on shares of Thermo Fisher Scientific in a research report on Wednesday, September 9th. They set an "outperform" rating on the stock. Two research analysts have rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, Thermo Fisher Scientific presently has an average rating of "Moderate Buy" and an average price target of $683.64.
Get Our Latest Research Report on TMO
Insider Activity
In related news, CEO Marc N. Casper sold 275 shares of the business's stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $627.05, for a total transaction of $172,438.75. Following the completion of the sale, the chief executive officer directly owned 123,925 shares in the company, valued at approximately $77,707,171.25. The trade was a 0.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Lisa P. Britt sold 2,831 shares of the stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $706.45, for a total value of $1,999,959.95. Following the completion of the transaction, the vice president directly owned 11,560 shares of the company's stock, valued at approximately $8,166,562. This represents a 19.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.33% of the stock is owned by corporate insiders.
Latest Thermo Fisher Scientific News
Here's some of the latest news about TMO:
Thermo Fisher Scientific Trading Down 2.9%
Shares of NYSE:TMO opened at $668.89 on Friday. Thermo Fisher Scientific Inc. has a 1 year low of $435.27 and a 1 year high of $727.56. The firm has a market capitalization of $247.84 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 2.82 and a beta of 0.84. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.81 and a quick ratio of 1.41. The business's 50 day moving average price is $678.63 and its 200-day moving average price is $559.30.
Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last issued its quarterly earnings results on Wednesday, October 21st. The medical research company reported $6.68 EPS for the quarter, topping the consensus estimate of $6.40 by $0.28. The company had revenue of $12.14 billion during the quarter, compared to analyst estimates of $11.95 billion. Thermo Fisher Scientific had a net margin of 14.94% and a return on equity of 17.33%. The firm's revenue was up 9.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.79 EPS. On average, equities research analysts forecast that Thermo Fisher Scientific Inc. will post 25.26 earnings per share for the current fiscal year.
Thermo Fisher Scientific Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, January 15th. Stockholders of record on Tuesday, December 15th will be paid a dividend of $0.47 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.3%. Thermo Fisher Scientific's payout ratio is currently 9.92%.
About Thermo Fisher Scientific
(
Free Report)
Thermo Fisher Scientific develops and supplies products and services used in scientific research, clinical diagnostics, and pharmaceutical and biotechnology manufacturing. Its offerings include laboratory instruments, reagents and consumables, analytical equipment, diagnostic tests, and services that support drug development and clinical research. The company operates through businesses focused on life sciences, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Thermo Fisher Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.
While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.